10:49:10 EST Sat 09 Nov 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:TTOO - T2 BIOSYSTEMS INC - http://www.t2biosystems.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TTOO - Q0.10.5073·0.602.00.5799-0.1318-18.51,506.87272,9820.7194  0.7194  0.55748.3799  0.6319:52:12Nov 0515 min RT 2¢

Recent Trades - Last 10 of 2982
Time ETExPriceChangeVolume
19:52:12Q0.59-0.12171
19:51:09Q0.59-0.1217120
19:48:06Q0.5884-0.12336
19:47:14Q0.5899-0.12187
19:46:22Q0.59-0.1217258
19:41:06Q0.58-0.1317100
19:29:26Q0.57-0.1417100
19:29:26Q0.57-0.141712
19:28:38Q0.57-0.1417100
19:28:38Q0.56-0.151710

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-11-05 08:00U:TTOONews ReleaseT2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024
2024-10-08 16:05U:TTOONews ReleaseT2 Biosystems to Host Business Update Call on October 10, 2024
2024-10-08 09:00U:TTOONews ReleaseT2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform
2024-10-07 09:05U:TTOONews ReleaseT2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
2024-10-07 09:00U:TTOONews ReleaseT2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results
2024-09-23 09:00U:TTOONews ReleaseT2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture
2024-09-20 09:00U:TTOONews ReleaseT2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
2024-09-16 09:00U:TTOONews ReleaseT2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients
2024-09-09 09:00U:TTOONews ReleaseT2 Biosystems Provides Updates on its New Product Development Pipeline Progress
2024-08-27 16:05U:TTOONews ReleaseT2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
2024-08-01 16:05U:TTOONews ReleaseT2 Biosystems to Attend Upcoming Investor Conferences
2024-07-29 16:05U:TTOONews ReleaseT2 Biosystems Announces Second Quarter 2024 Financial Results
2024-07-29 16:02U:TTOONews ReleaseT2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor
2024-07-22 16:05U:TTOONews ReleaseT2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
2024-06-25 09:00U:TTOONews ReleaseT2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
2024-05-22 09:00U:TTOONews ReleaseT2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements
2024-05-17 16:05U:TTOONews ReleaseT2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2024-05-15 07:00U:TTOONews ReleaseT2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2024-05-14 17:00U:TTOONews ReleaseT2 Biosystems Announces CRG's Conversion from Preferred Stock to Common Stock
2024-05-07 09:00U:TTOONews ReleaseT2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease